Personal information

Glioma, Aspirin, Pharmacology
United Kingdom

Activities

Employment (8)

Edge Hill University: Ormskirk, Lancashire, GB

2021-01-04 to present | Associate Head PG/CPD Medical Education, Programme Lead Masters in Medicine (MMed)
Employment
Source: Self-asserted source
Philip Welsby

Edge Hill University: Ormskirk, Lancashire, GB

2019-03-01 to 2021-01-04 | Senior Lecturer & MMed Programme Lead (Medical School)
Employment
Source: Self-asserted source
Philip Welsby

University of Central Lancashire: Preston, Lancashire, GB

2011-05 to 2019-03-01 | Senior Lecturer in Pharmacology (Pharmacy and Biomedical Sciences)
Employment
Source: Self-asserted source
Philip Welsby

National University of Ireland - Galway: Galway, Galway, IE

2007-05 to 2010-12 | Lecturer in Pharmacology (Pharmacology)
Employment
Source: Self-asserted source
Philip Welsby

Trinity College Dublin: Dublin, IE

2003-08 to 2007-05 | Postdoctoral Research Fellow (Physiology)
Employment
Source: Self-asserted source
Philip Welsby

Dublin Institute of Technology: Dublin, Dublin, IE

2004 to 2007 | Lecturer in Pharmacology (Part Time)
Employment
Source: Self-asserted source
Philip Welsby

University of Virginia: Charlottesville, VA, US

2001-11 to 2003-08 | Postdoctoral Fellow (Pharmacology)
Employment
Source: Self-asserted source
Philip Welsby

Pfizer Global Research and Development Europe: Sandwich, Kent, GB

1996-08 to 1998-08 | Research Associate (Urogentials)
Employment
Source: Self-asserted source
Philip Welsby

Education and qualifications (3)

Acadamh na hOllscolaíochta Gaeilge, OÉ, Gaillimh: Galway, IE

2008-09 to 2010-07 | Dioplóma sa Ghaeilge
Education
Source: Self-asserted source
Philip Welsby

University of Glasgow: Glasgow, Glasgow, GB

1998-09 to 2001-10 | PhD Biochemistry and Molecular Pharmacology (Biochemistry)
Education
Source: Self-asserted source
Philip Welsby

University of Aberdeen: Aberdeen, Aberdeen, GB

1992-09 to 1996-07 | BSc (Hons) Pharmacology (Pharmacology)
Education
Source: Self-asserted source
Philip Welsby

Professional activities (1)

British Pharmacological Society: London, GB

2016-02 to present
Membership
Source: Self-asserted source
Philip Welsby

Funding (4)

Guava EasyCyte™ HT Sampling Flow Cytometer – a state of the art benchtop flow cytometer

2014-03 to present | Award
University of Central Lancashire (Preston, GB)
Source: Self-asserted source
Philip Welsby

Live and fixed cell fluorescent imaging system to support research projects

2012-11 to present | Award
University of Central Lancashire (Preston, GB)
Source: Self-asserted source
Philip Welsby

IRCSET Embark

2008-10 to 2011-09 | Grant
IRCSET (Dublin, IE)
Source: Self-asserted source
Philip Welsby

Millenium Fund

2007-10 to 2008-09 | Award
NUI Galway (Galway, IE)
Source: Self-asserted source
Philip Welsby

Works (21)

Multidisciplinary docking, kinetics and X-ray crystallography studies of baicalein acting as a glycogen phosphorylase inhibitor and determination of its' potential against glioblastoma in cellular models.

Chemico-biological interactions
2023-06-03 | Journal article
Contributors: Mathomes RT; Koulas SM; Tsialtas I; Stravodimos G; Welsby PJ; Psarra AG; Stasik I; Leonidas DD; Hayes JM
Source: Self-asserted source
Philip Welsby
grade
Preferred source (of 2)‎

The Effect of Cryoprotectants and Storage Conditions on the Transfection Efficiency, Stability, and Safety of Lipid-Based Nanoparticles for mRNA and DNA Delivery.

Advanced healthcare materials
2023-03-21 | Journal article
Contributors: Kafetzis KN; Papalamprou N; McNulty E; Thong KX; Sato Y; Mironov A; Purohit A; Welsby PJ; Harashima H; Yu-Wai-Man C et al.
Source: Self-asserted source
Philip Welsby

Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β.

Journal of medicinal chemistry
2021-01-26 | Journal article
Source: Self-asserted source
Philip Welsby

Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.

Materials Science & Engineering C
2018-10 | Journal article
Source: Self-asserted source
Philip Welsby

Aspirin or its analogues, a treatment for glioblastoma?

Neuro-Oncology
2018-01 | Journal article
Contributors: Sabouni J; Perry C; Nicholl I; Snape T; Welsby G; Welsby P
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

Phytochemicals - an alternative therapy for glioblastoma?

Neuro-Oncology
2018-01 | Journal article
Contributors: Salim S; Snape T; Welsby P; Welsby G
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia.

2017-02 | Journal article
Contributors: Thakor FK; Wan KW; Welsby PJ; Welsby G
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

P51PREPARATION OF ASIATIC ACID LOADED NANOPARTICLES FOR DELIVERY ACROSS THE BLOOD BRAIN BARRIER AND ITS EFFECTS ON GLIOBLASTOMA CELLS IN VITRO.

2014-10 | Journal article
Contributors: Thakor F; Welsby PJ; Wan K; Welsby G
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

P17.68CHARACTERISATION OF A NOVEL ASPIRIN ANALOGUE IN MALIGNANT GLIOMA.

2014-09 | Journal article
Contributors: Petinou V; Perry CJ; Nicholl ID; Singh J; Lea RW; Welsby PJ
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

CHARACTERISATION OF THE EFFECTS OF CHRONIC ASPIRIN TREATMENT ON THE VIABILITY AND PROLIFERATION OF STAGE 4 GLIOBLASTOMA CELLS

Diffusion- The UCLan Journal of Undergraduate Research
2013 | Journal article
Part of ISSN: ISSN 1759-6777
Source: Self-asserted source
Philip Welsby

Effects of Diabetes-Induced Hyperglycemia in the Heart: Biochemical and Structural Alterations

Diabetic Cardiomyopathy
2013-12-02 | Book chapter
Source: Self-asserted source
Philip Welsby

Anti-cancer effects and mechanism of action of aspirin analogues in the treatment of glioma.

British Neuro Oncology Society
2012-09 | Conference abstract
Source: Self-asserted source
Philip Welsby

NEUROPROTECTIVE EFFECTS OF HISTAMINE AND CARNOSINE IN MODELS OF NEURONAL STRESS

Neuroscience Ireland
2010-09 | Conference abstract
Source: Self-asserted source
Philip Welsby

Neuroprotective effects of histamine in PC12 cells.

3rd Annual Neuroscience Ireland Conference
2010-04 | Conference abstract
Source: Self-asserted source
Philip Welsby

Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus.

2009-01 | Journal article
Contributors: Welsby PJ; Rowan MJ; Anwyl R
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP.

2007-07 | Journal article
Contributors: Welsby PJ; Rowan MJ; Anwyl R
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus.

2006-12 | Journal article
Contributors: Welsby P; Rowan M; Anwyl R
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase II.

2006-09 | Journal article
Contributors: Yao J; Davies LA; Howard JD; Adney SK; Welsby PJ; Howell N; Carey RM; Colbran RJ; Barrett PQ
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II.

2003-11 | Journal article
Contributors: Welsby PJ; Wang H; Wolfe JT; Colbran RJ; Johnson ML; Barrett PQ
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit.

2002-10 | Journal article
Contributors: Welsby PJ; Carr IC; Wilkinson G; Milligan G
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists.

2002-05 | Journal article
Contributors: Welsby PJ; Kellett E; Wilkinson G; Milligan G
Source: Self-asserted source
Philip Welsby via Europe PubMed Central

Peer review (4 reviews for 1 publication/grant)

Review activity for Journal of neuroinflammation (4)